AROMHA, INC.

POTOMAC, MD · Founded 2020 · CIK 0002047430 · Medtech · Private

Web-based olfactory test battery app paired with mailable smell cards for at-home detection of Lewy Body pathology in asymptomatic individuals

aromha.com →
Grants
$4.2M
4 awards
Sector median: 1
Raised
$425K
3 Form D · Sep 2026
0 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD$999,982
Federal grantDepartment of Health and Human Services · Phase II · Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD$1,468,541
Federal grantDepartment of Health and Human Services · Phase I · Digital Accessible Remote Olfactory Mediated Health Assessments for Lewy Body Disease$493,964
Private capital raisedForm D · SEC$100,000
Federal grantDepartment of Health and Human Services · Phase II · Digital Accessible Remote Olfactory Mediated Health Assessments forPreclinical AD$1,249,670
Private capital raisedForm D · SEC$250,000
Private capital raisedForm D · SEC$75,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1607Emblok, Inc.—$6.0M
1608CereVu Medical, Inc.——
1609TREYSTA MEDICAL TECHNOLOGIES INC—$183K
1610AROMHA, INC.—$425K
1611WR Biotech, LLC——
1612Buck Surgical, Inc.—$300K
1613NeoTherma Oncology Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Sean ReinekeDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.